1.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: OSI-906-301, 2009-012820-97, NCT00924989
|
|
2.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: CASE-6810, CASE 6810, 8872, NCT01533246
|
|
3.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: OSI-906-101, 2006-005937-39, NCT00514007
|
|
4.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: OSI-906-102, 2006-005938-20, NCT00514306
|
|
5.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: OSI-906-103, 2008-001743-20, NCT00739453
|
|
6.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: SCRI GI 124, NCT01154335
|